Aura Biosciences
Aura Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 6 tracked investors.
About Aura Biosciences
Based in the United States, Aura Biosciences is a startup founded in 2018. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 6 investors associated with the company.
Aura Biosciences is a clinical-stage biotechnology company developing precision therapies for solid tumors with the goal of preserving organ function; its lead candidate belzupacap sarotalocan (bel-sar, AU-011) is in a global Phase 3 trial for early choroidal melanoma and is being evaluated in other ocular oncology indications and bladder cancer.
Explore Aura Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.